BACKGROUND:HIV patients with wasting are at increased risk of opportunistic complications and fatality. OBJECTIVE: We hypothesized that augmenting dietary intake with high-biologic-value protein would enhance weight and lean tissue in weight-stable subjects with a prior unintentional weight loss of >3%. DESIGN:Fifty-nine subjects with HIV RNA concentrations <5000 copies/mL were randomly assigned to receive a 280-kcal supplement containing 40 g whey protein or a matched isocaloric control supplement without added protein twice daily for 12 wk. RESULTS: Before the study, intake of total energy and protein exceeded estimated requirements (44.3 +/- 12.6 kcal x kg(-1) x d(-1) and 1.69 +/- 0.55 g x kg(-1) x d(-1), respectively). Both supplements failed to increase total energy intake because of decreases in self-selected food intake. Changes in weight (0.8 +/- 2.4 and 0.7 +/- 2.4 kg) and lean body mass (0.3 +/- 1.4 and 0.3 +/- 1.5 kg) did not differ significantly between the whey protein and control groups, respectively. Waist-to-hip ratio improved more with whey protein (-0.02 +/- 0.05) than with the control (0.01 +/- 0.03; P = 0.025) at week 6 but not at week 12. Fasting triacylglycerol increased by 39 +/- 98 mg/dL with the control supplement and decreased by 16 +/- 62 mg/dL with whey protein at week 12 (P = 0.03). CD4 lymphocytes increased by 31 +/- 84 cells/mm(3) with whey protein and decreased by 5 +/- 124 cells/mm(3) with the control supplement at 12 wk (P = 0.03). Gastrointestinal symptoms occurred more often with whey protein. CONCLUSIONS: A whey protein supplement did not increase weight or lean body mass in HIV-positive subjects who were eating adequately, but it did increase CD4 cell counts. The control supplement with rapidly assimilable carbohydrate substituted for protein increased cardiovascular disease risk factors. Careful dietary and weight history should be obtained before starting nutritional supplements in subjects with stable weight loss and good viral control.
RCT Entities:
BACKGROUND: HIV patients with wasting are at increased risk of opportunistic complications and fatality. OBJECTIVE: We hypothesized that augmenting dietary intake with high-biologic-value protein would enhance weight and lean tissue in weight-stable subjects with a prior unintentional weight loss of >3%. DESIGN: Fifty-nine subjects with HIV RNA concentrations <5000 copies/mL were randomly assigned to receive a 280-kcal supplement containing 40 g whey protein or a matched isocaloric control supplement without added protein twice daily for 12 wk. RESULTS: Before the study, intake of total energy and protein exceeded estimated requirements (44.3 +/- 12.6 kcal x kg(-1) x d(-1) and 1.69 +/- 0.55 g x kg(-1) x d(-1), respectively). Both supplements failed to increase total energy intake because of decreases in self-selected food intake. Changes in weight (0.8 +/- 2.4 and 0.7 +/- 2.4 kg) and lean body mass (0.3 +/- 1.4 and 0.3 +/- 1.5 kg) did not differ significantly between the whey protein and control groups, respectively. Waist-to-hip ratio improved more with whey protein (-0.02 +/- 0.05) than with the control (0.01 +/- 0.03; P = 0.025) at week 6 but not at week 12. Fasting triacylglycerol increased by 39 +/- 98 mg/dL with the control supplement and decreased by 16 +/- 62 mg/dL with whey protein at week 12 (P = 0.03). CD4 lymphocytes increased by 31 +/- 84 cells/mm(3) with whey protein and decreased by 5 +/- 124 cells/mm(3) with the control supplement at 12 wk (P = 0.03). Gastrointestinal symptoms occurred more often with whey protein. CONCLUSIONS: A whey protein supplement did not increase weight or lean body mass in HIV-positive subjects who were eating adequately, but it did increase CD4 cell counts. The control supplement with rapidly assimilable carbohydrate substituted for protein increased cardiovascular disease risk factors. Careful dietary and weight history should be obtained before starting nutritional supplements in subjects with stable weight loss and good viral control.
Authors: C L Gibert; D A Wheeler; G Collins; M Madans; N Muurahainen; S S Raghavan; G Bartsch Journal: J Acquir Immune Defic Syndr Date: 1999-11-01 Impact factor: 3.731
Authors: A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon Journal: J Clin Endocrinol Metab Date: 2000-07 Impact factor: 5.958
Authors: Andrea E Cassidy; Lawrence F Bielak; Yan Zhou; Patrick F Sheedy; Stephen T Turner; Jerome F Breen; Philip A Araoz; Iftikhar J Kullo; Xihong Lin; Patricia A Peyser Journal: Circulation Date: 2005-04-19 Impact factor: 29.690
Authors: Kathleen Mulligan; Robert Zackin; Rebecca A Clark; Beverly Alston-Smith; Tun Liu; Fred R Sattler; Thomas B Delvers; Judith S Currier Journal: Arch Intern Med Date: 2005-03-14
Authors: Alice M Tang; Denise L Jacobson; Donna Spiegelman; Tamsin A Knox; Christine Wanke Journal: J Acquir Immune Defic Syndr Date: 2005-09-01 Impact factor: 3.731
Authors: F Carbonnel; C Maslo; L Beaugerie; F Carrat; E Wirbel; C Aussel; J G Gobert; P M Girard; J P Gendre; J Cosnes; W Rozenbaum Journal: AIDS Date: 1998-10-01 Impact factor: 4.177
Authors: M Silva; P R Skolnik; S L Gorbach; D Spiegelman; I B Wilson; M G Fernández-DiFranco; T A Knox Journal: AIDS Date: 1998-09-10 Impact factor: 4.177
Authors: John R Koethe; Benjamin H Chi; Karen M Megazzini; Douglas C Heimburger; Jeffrey S A Stringer Journal: Clin Infect Dis Date: 2009-09-01 Impact factor: 9.079
Authors: Mette F Olsen; Alemseged Abdissa; Pernille Kæstel; Markos Tesfaye; Daniel Yilma; Tsinuel Girma; Jonathan C K Wells; Christian Ritz; Christian Mølgaard; Kim F Michaelsen; Dilnesaw Zerfu; Søren Brage; Ase B Andersen; Henrik Friis Journal: BMJ Date: 2014-05-15
Authors: Wesley K Lefferts; Jacqueline A Augustine; Nicole L Spartano; William E Hughes; Matthew C Babcock; Brigid K Heenan; Kevin S Heffernan Journal: Nutrients Date: 2020-04-10 Impact factor: 5.717